ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 04/24/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. KLTO, NLSP, SXTP, ADIL, NCNA, CPHI, PWUP, MBIO, ONCO, and ATNFShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Klotho Neurosciences (KLTO), NLS Pharmaceutics (NLSP), 60 Degrees Pharmaceuticals (SXTP), Adial Pharmaceuticals (ADIL), NuCana (NCNA), China Pharma (CPHI), PowerUp Acquisition (PWUP), Mustang Bio (MBIO), Onconetix (ONCO), and 180 Life Sciences (ATNF). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Klotho Neurosciences NLS Pharmaceutics 60 Degrees Pharmaceuticals Adial Pharmaceuticals NuCana China Pharma PowerUp Acquisition Mustang Bio Onconetix 180 Life Sciences ASLAN Pharmaceuticals (NASDAQ:ASLN) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings. Do analysts prefer ASLN or KLTO? ASLAN Pharmaceuticals presently has a consensus target price of $72.00, indicating a potential upside of 11,900.00%. Given ASLAN Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe ASLAN Pharmaceuticals is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASLAN Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in ASLN or KLTO? 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are owned by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are owned by insiders. Comparatively, 2.0% of Klotho Neurosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor ASLN or KLTO? In the previous week, Klotho Neurosciences had 2 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 2 mentions for Klotho Neurosciences and 0 mentions for ASLAN Pharmaceuticals. ASLAN Pharmaceuticals' average media sentiment score of 0.00 equaled Klotho Neurosciences'average media sentiment score. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Klotho Neurosciences Neutral Is ASLN or KLTO more profitable? Klotho Neurosciences' return on equity of 0.00% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Klotho Neurosciences N/A N/A -25.89% Does the MarketBeat Community prefer ASLN or KLTO? ASLAN Pharmaceuticals received 200 more outperform votes than Klotho Neurosciences when rated by MarketBeat users. CompanyUnderperformOutperformASLAN PharmaceuticalsOutperform Votes20063.49% Underperform Votes11536.51% Klotho NeurosciencesN/AN/A Which has preferable earnings & valuation, ASLN or KLTO? Klotho Neurosciences has lower revenue, but higher earnings than ASLAN Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Klotho NeurosciencesN/AN/A$1.35MN/AN/A SummaryASLAN Pharmaceuticals beats Klotho Neurosciences on 7 of the 11 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$6.68B$5.44B$7.80BDividend YieldN/A3.17%5.43%4.31%P/E Ratio-0.037.1422.1418.40Price / Sales0.10238.89389.70101.29Price / CashN/A65.6738.2034.62Price / Book-0.096.266.664.18Net Income-$44.22M$142.48M$3.21B$247.71M7 Day PerformanceN/A7.91%5.83%6.45%1 Month PerformanceN/A-6.03%-4.32%-3.14%1 Year Performance-83.26%-0.96%17.83%5.40% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flat$72.00+11,900.0%N/A$1.23M$12M-0.0330KLTOKlotho NeurosciencesN/A$0.17+2.4%N/AN/A$4.87MN/A0.00N/AGap UpNLSPNLS PharmaceuticsN/A$1.45+7.4%N/A+1,032.9%$4.86MN/A0.006SXTP60 Degrees Pharmaceuticals1.1652 of 5 stars$3.26+10.1%N/A+152.6%$4.80M$607,574.00-0.323Analyst ForecastNews CoveragePositive NewsADILAdial Pharmaceuticals3.1909 of 5 stars$0.72+2.1%$8.00+1,003.8%-60.4%$4.77MN/A-0.2220Positive NewsGap DownNCNANuCana3.0602 of 5 stars$0.83+10.6%$25.00+2,913.5%-85.7%$4.71MN/A-0.0830Positive NewsCPHIChina PharmaN/A$0.14-0.8%N/A-94.3%$4.61M$4.53M0.00250Analyst ForecastNews CoveragePWUPPowerUp AcquisitionN/A$0.59+11.3%N/A-95.4%$4.58MN/A0.00N/AHigh Trading VolumeMBIOMustang Bio2.1101 of 5 stars$1.36-2.2%$100.00+7,252.9%-93.2%$4.50MN/A-0.02100ONCOOnconetix0.7728 of 5 stars$0.07+11.7%N/A-98.5%$4.49M$1.87M0.0012ATNF180 Life SciencesN/A$0.85+0.3%N/A-50.8%$4.42MN/A0.007Analyst ForecastNews Coverage Related Companies and Tools Related Companies KLTO Alternatives NLSP Alternatives SXTP Alternatives ADIL Alternatives NCNA Alternatives CPHI Alternatives PWUP Alternatives MBIO Alternatives ONCO Alternatives ATNF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASLN Stock Free ASLN Stock Alerts